Trexquant Investment LP Increases Stock Position in Viemed Healthcare, Inc. $VMD

Key Points

• Trexquant Investment LP increased its stake in Viemed Healthcare, Inc. (NASDAQ: VMD) by 68.9%, owning approximately 0.25% of the company, valued at $717,000.
• Other institutional investors significantly boosted their holdings in Viemed Healthcare, with GSA Capital Partners increasing their stake by 497.7%
• Director Nitin Kaushal sold 34,100 shares at an average price of $7.01, resulting in a 21.19% decrease in his ownership of the stock.

Trexquant Investment LP grew its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 68.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 98,531 shares of the company's stock after acquiring an additional 40,185 shares during the period. Trexquant Investment LP owned about 0.25% of Viemed Healthcare worth $717,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of VMD. GSA Capital Partners LLP grew its stake in shares of Viemed Healthcare by 497.7% during the first quarter. GSA Capital Partners LLP now owns 149,791 shares of the company's stock worth $1,090,000 after purchasing an additional 124,731 shares in the last quarter. Nuveen LLC acquired a new position in shares of Viemed Healthcare during the first quarter worth $787,000. Segall Bryant & Hamill LLC grew its stake in shares of Viemed Healthcare by 252.1% during the first quarter. Segall Bryant & Hamill LLC now owns 130,229 shares of the company's stock worth $948,000 after purchasing an additional 93,242 shares in the last quarter. Millennium Management LLC acquired a new position in shares of Viemed Healthcare during the fourth quarter worth $573,000. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of Viemed Healthcare during the fourth quarter worth $449,000. Institutional investors and hedge funds own 74.24% of the company's stock.

Insider Activity at Viemed Healthcare

In related news, President Michael Moore sold 50,090 shares of the business's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.33, for a total value of $367,159.70. Following the completion of the sale, the president directly owned 126,343 shares of the company's stock, valued at $926,094.19. The trade was a 28.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Jerome Cambre sold 4,880 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total transaction of $35,721.60. Following the completion of the sale, the vice president directly owned 84,191 shares of the company's stock, valued at approximately $616,278.12. This trade represents a 5.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 97,922 shares of company stock valued at $703,886 over the last ninety days. Insiders own 20.00% of the company's stock.

Viemed Healthcare Stock Down 2.0%

Shares of VMD stock traded down $0.14 on Friday, reaching $6.78. 315,330 shares of the stock were exchanged, compared to its average volume of 218,307. The company has a current ratio of 1.48, a quick ratio of 1.37 and a debt-to-equity ratio of 0.02. The business's 50 day moving average price is $6.77 and its 200 day moving average price is $6.90. The company has a market capitalization of $263.00 million, a price-to-earnings ratio of 19.94 and a beta of 1.38. Viemed Healthcare, Inc. has a twelve month low of $5.93 and a twelve month high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.08 EPS for the quarter, hitting analysts' consensus estimates of $0.08. The firm had revenue of $63.06 million during the quarter, compared to the consensus estimate of $63.50 million. Viemed Healthcare had a net margin of 5.80% and a return on equity of 10.38%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.